Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 38557-71-0 | MDL No. : | MFCD00055032 |
Formula : | C5H5ClN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | CKUVSPQGYLELRG-UHFFFAOYSA-N |
M.W : | 128.56 | Pubchem ID : | 7170095 |
Synonyms : |
|
Num. heavy atoms : | 8 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.2 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 32.01 |
TPSA : | 25.78 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.35 cm/s |
Log Po/w (iLOGP) : | 1.52 |
Log Po/w (XLOGP3) : | 1.04 |
Log Po/w (WLOGP) : | 1.44 |
Log Po/w (MLOGP) : | 0.13 |
Log Po/w (SILICOS-IT) : | 2.04 |
Consensus Log Po/w : | 1.23 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.85 |
Solubility : | 1.83 mg/ml ; 0.0142 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.17 |
Solubility : | 8.66 mg/ml ; 0.0673 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.62 |
Solubility : | 0.311 mg/ml ; 0.00242 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.93 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73% | at 130℃; Sealed tube | step 3: Into a 5-L sealed tube was placed 2-(6-chloropyrazin-2-yl)acetic acid (220 g, 1.27 mol, 1.00 equiv) and water (3 L). The resulting solution was stirred overnight at 130° C., cooled and extracted with Et2O 2×3 L of ether. The organic layers were combined, dried (Na2SO4), filtered and concentrated in vacuo to afford 238 g (73percent) of 2-chloro-6-methylpyrazine as a yellow solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | at 100℃; for 2 h; | General procedure: (0.1mole) of 2-halo nitrogen heterocycle and (0.5 mole) of hydrazine hydrate were mixed together in a 250mL round bottom flask equipped with reflux condenser and wereheated at 100oC, progress of the reaction was monitored byTLC. After completion of the reaction the reaction mixture was cooled to (-5-0oC) for 14hr and the precipitated solid was filtered and washed with two 5ml portions of ice coldwater and dried to give the compound 1 in good yield. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With sodium methylate In methanol at 60 - 70℃; for 16 h; | To a suspension of 2-chloro-6-methylpyrazine (24 g, 186.7 mmol) in anhydrous MeOH (240 mL) was added NaOMe (12.1 g, 224 mmol). The mixture was stirred at 60-70°C for 16hours. The mixture was cooled and filtered. The filtrate was concentrated in vacuo to give 2- methoxy-6-methylpyrazine (22 g, 95percent yield). 1H NMR (CDCI3400 MHz): 7.98 (s, 1H), 7.94(s, 1H), 3.91 (s, 3H), 3.40 (s, 3H). LC-MS: tR = 1.47 mm (method 14), mlz= 124.8 [M + H]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | at 60 - 70℃; for 16 h; | To a suspension of 2-chloro-6-methylpyrazine (24 g, 186.7 mmol) in anhydrous MeOH (240 mL) was added NaOMe (12.1 g, 224 mmol). The mixture was stirred at 60-70°C for 16 hours. The mixture was cooled and filtered. The filtrate was concentrated in vacuo to give 2- methoxy-6-methylpyrazine (22 g, 95percent yield). 1H NMR (CDCI3400 MHz): δ 7.98 (s, 1 H), 7.94 (s, 1 H), 3.91 (s, 3H), 3.40 (s, 3H). LC-MS: t = 1.47 min (method 14), m/z = 124.8 [M + H]+. |
95% | at 60 - 70℃; for 16 h; | To a suspension of 2-chloro-6-methylpyrazine (24 g, 186.7 mmol) in anhydrous MeOH (240 mL) was added NaOMe (12.1 g, 224 mmol). The mixture was stirred at 60-70°C for 16 hours. The mixture was cooled and filtered. The filtrate was concentrated in vacuo to give 2- methoxy-6-methylpyrazine (22 g, 95percent yield). H NMR (CDCI3400 MHz): (5 7.98 (s, 1 H), 7.94 (s, 1 H), 3.91 (s, 3H), 3.40 (s, 3H). LC-MS: tR = 1.47 min (method 14), m/z = 124.8 [M + H]+. |
[ 874114-34-8 ]
6-Chloropyrazine-2-carbaldehyde
Similarity: 0.88
[ 88625-24-5 ]
5-Chloropyrazine-2-carbaldehyde
Similarity: 0.86
[ 874114-34-8 ]
6-Chloropyrazine-2-carbaldehyde
Similarity: 0.88
[ 88625-24-5 ]
5-Chloropyrazine-2-carbaldehyde
Similarity: 0.86